Eat more walnuts to help you stay away from colorectal cancer

Share This Post

Nut-rich diets, such as walnuts, have been shown to play a role in heart health and reducing colorectal cancer. According to a new study, the impact of walnuts on intestinal microbes and the existence of trillions of microbes or bacteria in the gastrointestinal tract may be some of the health benefits. Research results published in the Journal of Nutrition show that edible walnuts not only affect the secondary bile acids produced by intestinal flora and microorganisms, but also reduce the LDL-cholesterol levels of adults participating in the study. Gastrointestinal health is good.

“We found that when you eat walnuts, it increases the microbes that produce butyric acid, which is a beneficial metabolite that is beneficial to colon health.” Therefore, the interaction of walnuts with the microbiome helps produce some health effects, “Hannah Holscher said.

 

In this study, the diet of 18 healthy male and female adults included 0 grams of walnuts or 42 grams—about one-third of a cup or more walnuts in one palm—for two or three weeks. Fecal and blood samples were collected at the beginning and end of each phase to assess the secondary results of the study, including the impact of walnut consumption on fecal microorganisms and bile acids and healthy metabolic markers. The consumption of walnuts leads to the relative abundance of three bacteria of interest: fecal bacteria, red blood cells, and Clostridium.

The results also showed that compared with the control group, the consumption of walnuts reduced secondary bile acids. Hannah Holscher explained that people with a higher incidence of colorectal cancer have higher levels of secondary bile acids. Secondary bile acids can damage cells in the gastrointestinal tract, and microorganisms can produce secondary bile acids. If we can reduce the secondary bile acid in the intestines, it can also help human health.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Gamma Delta T Cell therapy in Malaysia
CAR T-Cell therapy

Gamma Delta T Cell Therapy in Malaysia: A Revolution in Cancer Treatment

Gamma Delta T Cell therapy is revolutionizing cancer treatment by harnessing the immune system’s power. This innovative approach is gaining momentum in Malaysia, a rising medical hub in Southeast Asia. With cutting-edge facilities, cost-effective treatments, and strong government support, Malaysia is advancing this therapy to offer hope to cancer patients. By focusing on research and international collaborations, the country is poised to lead the region in next-generation cancer care.

Gamma Delta T Cell therapy in Sinagpore
CAR T-Cell therapy

Gamma Delta T Cell Therapy in Singapore: A Revolutionary Approach for Late-Stage Cancer Treatment

Gamma Delta (GD) T Cell therapy is revolutionizing stage 4 cancer treatment, offering hope to metastatic cancer patients. At Singapore’s National University Hospital (NUH), the ANGELICA trials harness the unique tumor-targeting abilities of GD T cells. This cutting-edge therapy minimizes side effects, enhances survival rates, and improves quality of life. As a global leader in medical innovation, Singapore positions itself as a premier destination for advanced cancer therapies like GD T Cell therapy.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy